Guangyuan Lou

617 total citations
34 papers, 371 citations indexed

About

Guangyuan Lou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Guangyuan Lou has authored 34 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Guangyuan Lou's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (10 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Guangyuan Lou is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (10 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Guangyuan Lou collaborates with scholars based in China, United States and Italy. Guangyuan Lou's co-authors include Zhengbo Song, Xinmin Yu, Ting Wu, C.Y.R. Cheng, Xun Shi, Yiping Zhang, Wenxian Wang, Lan Shao, Takeshi Katsuragi and Kenji Honda and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Guangyuan Lou

31 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangyuan Lou China 12 195 161 47 47 37 34 371
Yao Hu China 14 75 0.4× 112 0.7× 55 1.2× 87 1.9× 29 0.8× 32 416
Hu Ren China 13 72 0.4× 95 0.6× 42 0.9× 83 1.8× 21 0.6× 50 364
Huaitao Wang China 12 112 0.6× 53 0.3× 32 0.7× 129 2.7× 12 0.3× 26 359
Qinghua Zhou China 10 64 0.3× 80 0.5× 46 1.0× 84 1.8× 65 1.8× 50 330
Karishma Shah United Kingdom 8 29 0.1× 243 1.5× 82 1.7× 45 1.0× 31 0.8× 19 425
Hatsuko Nasu Japan 11 105 0.5× 86 0.5× 134 2.9× 15 0.3× 110 3.0× 31 370
Matthias C. Burg Germany 12 68 0.3× 71 0.4× 99 2.1× 24 0.5× 163 4.4× 18 459
Guannan Zhang China 13 103 0.5× 50 0.3× 100 2.1× 129 2.7× 16 0.4× 44 556
Zhiming Li China 12 85 0.4× 108 0.7× 95 2.0× 45 1.0× 39 1.1× 40 475

Countries citing papers authored by Guangyuan Lou

Since Specialization
Citations

This map shows the geographic impact of Guangyuan Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangyuan Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangyuan Lou more than expected).

Fields of papers citing papers by Guangyuan Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangyuan Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangyuan Lou. The network helps show where Guangyuan Lou may publish in the future.

Co-authorship network of co-authors of Guangyuan Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Guangyuan Lou. A scholar is included among the top collaborators of Guangyuan Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangyuan Lou. Guangyuan Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Hong, et al.. (2025). Thermal performance and calculation method of framed precast concrete composite sandwich insulation wall panels. Journal of Building Engineering. 118. 114645–114645. 1 indexed citations
3.
Hu, Gangjian, Jing Guo, Jizhong Jiang, et al.. (2025). Capillary condensation-driven growth of perovskite nanowire arrays for multi-functional photodetector. Light Science & Applications. 14(1). 61–61. 13 indexed citations
4.
Shi, Xun, Lin Chen, Qiong He, et al.. (2025). An Open‐Label, Single‐Arm, Phase II Trial of Sintilimab Plus Anlotinib for Metastatic Non‐Small Cell Lung Cancer After First‐Line PD ‐(L)1 Inhibitor. Cancer Medicine. 14(17). e71191–e71191. 1 indexed citations
6.
Wang, Wenxian, Gen Lin, Yue Hao, et al.. (2022). Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study. European Journal of Cancer. 174. 21–30. 10 indexed citations
7.
Song, Zhengbo, Guangyuan Lou, Yina Wang, et al.. (2022). Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial. BMC Medicine. 20(1). 154–154. 10 indexed citations
8.
Wang, Wenxian, Lan Shao, Yibing Xu, et al.. (2022). Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study. BMC Pulmonary Medicine. 22(1). 179–179. 11 indexed citations
9.
Wang, Wenxian, Xiaodong Gu, Xingxiang Pu, et al.. (2022). Treatment outcomes and prognosis of patients with primary and acquired BRAF‐mutated non‐small cell lung cancer: A multicenter retrospective study. Genes Chromosomes and Cancer. 61(9). 530–541. 4 indexed citations
10.
Wang, Wenxian, Xiaodong Gu, Liping Wang, et al.. (2021). The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study. Cancer Immunology Immunotherapy. 71(7). 1693–1703. 35 indexed citations
11.
Xiong, Hui, et al.. (2019). Hesperidin: A Therapeutic Agent For Obesity. SHILAP Revista de lepidopterología. 4 indexed citations
12.
Wang, Wenxian, Guangyuan Lou, & Yiping Zhang. (2018). Olanzapine with ondansetron and dexamethasone for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in lung cancer. Medicine. 97(37). e12331–e12331. 13 indexed citations
13.
Song, Zhengbo, Xinmin Yu, Guangyuan Lou, Xun Shi, & Yiping Zhang. (2017). Salvage treatment with apatinib for advanced non-small-cell lung cancer. OncoTargets and Therapy. Volume 10. 1821–1825. 55 indexed citations
14.
Lou, Guangyuan, Xinmin Yu, & Zhengbo Song. (2016). Molecular Profiling and Survival of Completely Resected Primary Pulmonary Neuroendocrine Carcinoma. Clinical Lung Cancer. 18(3). e197–e201. 28 indexed citations
15.
Lou, Guangyuan, et al.. (2015). Studies into a high performance composite connection for high-rise buildings. Steel and Composite Structures. 19(4). 789–809. 4 indexed citations
16.
Shao, Lan, Beibei Zhang, Baochai Lin, et al.. (2014). Efficacy and safety of icotinib in Chinese patients with advanced nonsmall cell lung cancer after failure of chemotherapy. Chinese Medical Journal. 127(2). 266–271. 14 indexed citations
17.
Lou, Guangyuan, et al.. (2014). Association between polymorphisms in CHRNA3 and PHACTR2 gene and environment and NSCLC risk in Chinese population.. Acta Biochimica Polonica. 61(4). 765–8. 8 indexed citations
18.
Shao, Lan, Dan Su, Fajun Xie, et al.. (2012). Analysis of efficacy and survival of patients receiving second-line treatment for sensitive recurrent small-cell lung cancer. Tumori. 32(11). 892–898. 2 indexed citations
19.
Lou, Guangyuan, Ting Wu, & Zhaojun Bai. (2003). Disk brake squeal prediction using the ABLE algorithm. Journal of Sound and Vibration. 272(3-5). 731–748. 13 indexed citations
20.
Lou, Guangyuan, et al.. (2002). Vector and multithread computation of silencer performance prediction on a dual-processor PC workstation. Engineering Analysis with Boundary Elements. 26(1). 61–70. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026